Does SECUKINUMAB Cause Dermatitis? 294 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 294 reports of Dermatitis have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.2% of all adverse event reports for SECUKINUMAB.
294
Reports of Dermatitis with SECUKINUMAB
0.2%
of all SECUKINUMAB reports
0
Deaths
37
Hospitalizations
How Dangerous Is Dermatitis From SECUKINUMAB?
Of the 294 reports, 37 (12.6%) required hospitalization, and 6 (2.0%) were considered life-threatening.
Is Dermatitis Listed in the Official Label?
Yes, Dermatitis is listed as a known adverse reaction in the official FDA drug label for SECUKINUMAB.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Dermatitis?
DUPILUMAB (3,823)
ADAPALENE (2,088)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (1,615)
ADALIMUMAB (530)
METHOTREXATE (452)
ETANERCEPT (317)
INFLIXIMAB (268)
NIVOLUMAB (251)
DENOSUMAB (246)
RITUXIMAB (234)
Which SECUKINUMAB Alternatives Have Lower Dermatitis Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG